Manufacturing

Bill Gates' significant role in global health policy, especially through the Bill & Melinda Gates Foundation, raises critical questions about philanthropy's impact on international health and the sustainability of biologics manufacturing. The Foundation is known for its substantial

The biopharma industry stands at a transformative juncture as it reflects on the achievements of the past year and anticipates the evolving client requirements that will shape 2025 and beyond. Key insights from Subodh Deshmukh, CEO of Aragen Bioscience, highlight the crucial areas of focus for

Thermo Fisher Scientific is taking bold steps toward revolutionizing drug development through its innovative Accelerator Drug Development program. This strategy aims to streamline the complex process from preclinical stages to commercialization by integrating its contract research organization

Antibody development is integral to pushing the boundaries of research, diagnostics, and therapeutics. Characterized by their high specificity and affinity, antibodies are critical for detecting and neutralizing biological targets, leading to significant breakthroughs across various scientific

The US Food and Drug Administration (FDA) raised serious concerns about Sanofi's manufacturing facility in Framingham, Massachusetts, by issuing a Warning Letter for significant deviations from current Good Manufacturing Practice (cGMP) standards for drug substance production. This alarming

In an optimistic outlook at the 43rd JPM Conference in San Francisco, Thermo Fisher CEO Marc Casper underscored the firm's strategic adaptations and growth initiatives tailored to meet surging demand for GLP-1 diabetes and weight loss products. Thermo Fisher Scientific's extensive